Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema
Authors
Keywords
-
Journal
ALLERGY
Volume 69, Issue 3, Pages 305-314
Publisher
Wiley
Online
2014-02-18
DOI
10.1111/all.12303
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and construct validation of the angioedema quality of life questionnaire
- (2012) K. Weller et al. ALLERGY
- Safety and efficacy of icatibant self-administration for acute hereditary angioedema
- (2012) I. Boccon-Gibod et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Hereditary angio-oedema
- (2012) Hilary Longhurst et al. LANCET
- Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group
- (2011) M. Cicardi et al. ALLERGY
- Descriptive epidemiology of hereditary angioedema hospitalizations in the United States, 2004‐2007
- (2011) Marya D. Zilberberg et al. ALLERGY AND ASTHMA PROCEEDINGS
- Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial
- (2011) William R. Lumry et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Ecallantide (DX-88) for acute hereditary angioedema attacks: Integrated analysis of 2 double-blind, phase 3 studies
- (2011) Albert L. Sheffer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Home treatment of hereditary angioedema with icatibant administered by health care professionals
- (2011) Henriette Farkas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patients
- (2010) A. Zanichelli et al. ALLERGY
- Economic costs associated with acute attacks and long-term management of hereditary angioedema
- (2010) David A. Wilson et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema
- (2010) Bruce Zuraw et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Prospective Study of Rapid Relief Provided by C1 Esterase Inhibitor in Emergency Treatment of Acute Laryngeal Attacks in Hereditary Angioedema
- (2010) Timothy J. Craig et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema
- (2010) Bruce L. Zuraw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
- (2010) Marco Cicardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- 8. Hereditary angioedema
- (2008) M FRANK JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Hereditary Angioedema
- (2008) Bruce L. Zuraw NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started